# Full HMS Production Readiness Report - 2026-06-01

## 1. Executive Verdict

**Final decision: Release Candidate - Ship with fixes.**

The three previously blocking waiver items are now closed in source:

| Waiver ID | Flow | Status | Evidence |
| --- | --- | --- | --- |
| W-01 | BF-07 Lab results | Closed 2026-05-31 | `/staff/lab-results/new`, frontend unit/Playwright coverage, backend `LabResultIntegrationTest` |
| W-02 | BF-09 Inventory/pharmacy | Closed 2026-06-01 | `POST /api/v1/inventory/dispense`, item/lot/medical-record traceability, audit movement, staff UI, unit/integration/Playwright coverage |
| W-03 | BF-11 Notifications/reminders | Closed 2026-06-01 | `email_delivery_attempts`, safe `LOCAL_RECORD` staging provider, Gmail send-attempt recording, retry-preserving reminder failure behavior |

This report does **not** call HMS fully Production Ready because the broader P1 product and UX backlog remains open: fake/static UI actions, destructive confirmations outside inventory/lab delete, patient self-service scope decisions, signed-record/addendum policy, and drug/allergy interaction scope. The system is suitable as a release candidate after waiver closure, with release-owner sign-off required before a production claim.

## 2. Environment

| Item | Value |
| --- | --- |
| Repo | `D:\projects\hospital-management-system` |
| Verification date | 2026-06-01 |
| Baseline commit before this pass | `dc7051d3123127ccccc04c38a2a874cf53a26ca2` |
| Isolated compose project | `hmsprod20260601` |
| Frontend URL | `http://localhost:13003` |
| Backend URL | `http://localhost:18084` |
| API URL | `http://localhost:18084/api/v1` |
| Data policy | Synthetic release-demo data only |
| GitNexus | `npx.cmd gitnexus status` up to date at `dc7051d`; local CLI still lacks `detect_changes` |

## 3. Verification Summary

| Gate | Status | Evidence |
| --- | --- | --- |
| Backend `mvn.cmd verify` from `backend/` | PASS, 148 tests | `artifacts/production-readiness-2026-06-01/backend-mvn-verify-2026-06-01.log` |
| Frontend lint | PASS, 29 existing warnings | `frontend-lint-2026-06-01.log` |
| Frontend unit coverage | PASS, branch coverage 80.48% | `frontend-unit-coverage-2026-06-01.log` |
| Frontend build | PASS | `frontend-build-2026-06-01.log` |
| npm audit and production audit | PASS, 0 vulnerabilities | `npm-audit-2026-06-01.json`, `npm-audit-production-2026-06-01.json` |
| Docker release-demo rebuild | PASS | `docker-compose-up-build-2026-06-01.log` |
| Docker release-demo smoke | PASS | `docker-release-demo-smoke-2026-06-01.json` |
| Playwright release-data | PASS, 2 passed | `playwright-release-data-2026-06-01.log` |
| Playwright chromium CI | PASS, 183 passed, 1 skipped | `playwright-ci-2026-06-01.log` |
| Playwright integrated | PASS serialized, 92 passed, 3 expected skips | `playwright-integrated-2026-06-01.log` |
| Playwright UI | PASS, 323 passed, 1 skipped | `playwright-ui-2026-06-01.log` |
| Playwright visual | PASS, 14 passed | `playwright-visual-2026-06-01.log` |
| Secret scan | PASS, 0 high-confidence findings | `high-confidence-secret-scan-2026-06-01.log` |
| Backup/restore smoke | PASS | `postgres-backup-restore-check-2026-06-01.json` |
| Git diff whitespace check | PASS with line-ending warnings only | `git-diff-check-2026-06-01.log` |

Notes:
- The first integrated pass exposed origin mismatch when Playwright used `127.0.0.1` while the production bundle targeted `localhost`; rerun used `localhost` consistently.
- Parallel integrated runs showed isolated mobile timing/rate noise; the final serialized integrated run passed.
- Visual inventory baseline was intentionally updated because the real Dispense action is now visible.

## 4. BF-01 To BF-12 Status

| Flow | Status | Notes |
| --- | --- | --- |
| BF-01 Public discovery/booking | Passed | Public APIs, booking, and release-data checks passed. |
| BF-02 Staff auth/RBAC | Passed | Auth, logout, RBAC, and route guards passed. |
| BF-03 Admin operations | Passed with follow-up | Core pages pass; dashboard/export/static actions still need product cleanup. |
| BF-04 Scheduling/availability | Passed with follow-up | Core slot/template gates pass; destructive slot actions still need confirmation review. |
| BF-05 Queue/check-in/vitals | Passed | Queue and clinical intake UI gates pass. |
| BF-06 Doctor consultation/medical record/prescription | Passed with follow-up | Core record/PDF paths pass; signed-record and addendum policy remains open. |
| BF-07 Lab results | Passed | W-01 closed. |
| BF-08 Patient portal | Passed with follow-up | Read/profile flows pass; cancel/reschedule, messaging writes, support tickets remain product decisions. |
| BF-09 Inventory/pharmacy | Passed | W-02 closed with dispense workflow and stock/audit traceability. |
| BF-10 Finance | Passed with follow-up | Invoice/payment flows pass; void confirmation and admin pricing delete remain open. |
| BF-11 Notifications/reminders | Passed backend-only | W-03 closed with delivery-attempt evidence and retry-preserving failure handling. |
| BF-12 Release-demo UAT readiness | Passed | Docker release-demo smoke and release-data gate passed. |

## 5. Remaining Fix Plan

| Priority | Area | Required action |
| --- | --- | --- |
| P1 | UI truthfulness | Audit remaining `Missing API`, `Missing handler`, `Need review`, `Potential issue`, and `Unclear` rows in `business-flow-test-matrix.md`; disable, remove, or wire each visible action. |
| P1 | Destructive safety | Add explicit confirmation and conflict handling for invoice void, slot delete/block, user deactivate, department/room delete, and queue terminal actions. |
| P1 | Patient portal scope | Decide whether cancel/reschedule, message send/reply, record export/print, and support tickets are in or out of scope; enforce read-only states if out. |
| P2 | Clinical safety | Define signed-record locking/addendum behavior and explicitly document drug/allergy interaction scope. |
| P2 | Operations | Keep health, backup/restore, audit, privacy, and release-demo seed gates as recurring release checks. |

## 6. Release Decision

**Ship with fixes / Release Candidate.**

W-01, W-02, and W-03 are closed with executable evidence, and the release-focused verification suite passed after remediation. Do not market this as unconstrained Production Ready until a release owner accepts the remaining P1/P2 product and safety backlog or explicitly scopes it out.
